7-(6-(2-Hydroxypropan-2-yl)pyridin-3-yl)-1-(trans-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, 98.0%, 25mg

1-(3,3-Diethoxypropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 250mg

2-Bromo-4-(tert-butyl)-1-methoxybenzene, 95.0%, 1g

2-Chlorocyclododecan-1-one, 97%, 1g

5-Phenyl-1 H -[1,2,4]triazol-3-ylamine, 95.0%, 2.5g

3-Hydroxyisoxazole-5-carboxamide, 95.0%, 100mg

2,5-Difluorophenylboronic acid, 97.0%, 5g

Ethyl 2-amino-6-(3,5-dimethylisoxazol-4-yl)-5-methoxy-1H-indole-3-carboxylate, 98%, 250mg

Colonna capillare per GC ROTI®Cap-1701, 25 m, 0,25 mm, 0,25 µm, 1 Pezzo(i)

8-Bromo-6-methoxy-1,2,3,4-tetrahydroisoquinoline, 97%, 100mg

N-[4-(4-methylpiperazin-1-yl)-3'-[(morpholin-4-yl)methyl]-[1,1'-biphenyl]-3-yl]-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide, 95%, 25mg

1-oxa-8-azaspiro[4.5]decan-3-ol, 95.0%, 250mg

2-Chloro-5-hydroxypyrimidine>98.0%(GC)5g